Altitude Crest Partners »

Aligos Therapeutics shares owned by Altitude Crest Partners

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Altitude Crest Partners from 13F filings

Historical chart of Altitude Crest Partners investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Altitude Crest Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Altitude Crest Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9M 2.8M 0.66

More positions owned by Altitude Crest Partners

Legend Biotech Corp Sponsored Ads (LEGN)
Bridgebio Pharma (BBIO)
Danaher Corporation (DHR)
Argenx Se Sponsored Adr (ARGX)
BioMarin Pharmaceutical (BMRN)
Apellis Pharmaceuticals (APLS)
Roivant Sciences SHS (ROIV)
Kiniksa Pharmaceuticals Com Cl A (KNSA)
EXACT Sciences Corporation (EXAS)
Aligos Therapeutics (ALGS)
Ambrx Biopharma
Surrozen *w Exp 08/01/203 (SRZNW)

View all positions for Altitude Crest Partners

Top funds holding Aligos Therapeutics

Alyeska Investment Group
EcoR1 Capital
Vivo Capital
Altitude Crest Partners
Versant Venture Management
Tang Capital Management
Baker Bros. Advisors
Hillhouse Capital Advisors
Opaleye Management
Newtyn Management
Bank of America Corporation
Vanguard Group
Charles Schwab Investment Management
Millennium Management
Choate Investment Advisors

View all funds holding Aligos Therapeutics